GL1X · GenesisL1 explorer

Research workbench

Human SIRT2 in complex with a specific inhibitor, NPD11033

Analyse Human SIRT2 in complex with a specific inhibitor, NPD11033 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5Y0Z
Type
protein
Length
577 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NAD-dependent protein deacetylase sirtuin-2
EC
3.5.1.-
UniProt
Q8IXJ6
Ligands
8K9, ZN
Pockets
7 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-)protein28842% helix, 17% strandQ8IXJ6
BNAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-)protein28941% helix, 17% strandQ8IXJ6

Ligands and binding sites

  • 8K9 · (1~{R},9~{S})-11-[(2~{R})-3-[2,4-bis(2-methylbutan-2-yl)phenoxy]-2-oxidanyl-propyl]-7,11-diazatricyclo[7.3.1.0^{2,7}]trideca-2,4-dien-6-one · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18900.830.84848K9
25670.810.86508K9
32490.540.7628empty
4710.380.7921empty
51100.370.7426empty

Interfaces

1 interface between chains.

  • A–B · 755 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 5Y0Z · Human SIRT2 in complex with a specific inhibitor, NPD11033 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.